![Walter Lawrence, 95, reflects on the National Cancer Act, medicine, social justice, COVID-19, and Richmond's vanishing monuments](https://cdn.cancerletter.com/media/2020/08/23163630/32-summer-web_4x3.jpg)
![Walter Lawrence, 95, reflects on the National Cancer Act, medicine, social justice, COVID-19, and Richmond's vanishing monuments](https://cdn.cancerletter.com/media/2020/08/23163630/32-summer-web_4x3.jpg)
Cover Story
Conversation with The Cancer LetterCOVID-19 & CancerFree
In 1971, when the National Cancer Act was signed, Walter Lawrence, Jr., was one of the surgeons eager for a push forward, driven by rigorous science reviewed and funded by the federal government.
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for August 2020
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center
- Tweaking the existing systems is not the answer to drug shortages